Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Medistim ASA is a Norwegian company specializing in the development and commercialization of medical devices used in cardiac, vascular, and transplant surgery. Its core business focuses on intraoperative blood flow measurement technology, notably through its proprietary products like the VeriQ and MiraQ systems. These systems are crucial for ensuring optimal blood flow during surgeries, thus helping to improve clinical outcomes. Founded in 1984, Medistim is headquartered in Oslo, Norway, and operates with a global network, distributing its products worldwide. The company's strategic strengths lie in its specialized focus on niche surgical applications and its continued innovation in medical technology.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Medistim ASAJohnson & Johnson
Last price
kr 316.00$283.52
Currency
NOK
USD
kr 5.7B$675B
32.0042.59
kr 9.75$6.58
0.950.21
kr 10.50$5.28
2.56%1.91%
Sector
HealthHealth
Employees
159138,200
Ticker
Nkr MEDI$JNJ
Primary listing
XOSLNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in NkrMEDI or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.